Literature DB >> 23436727

C-terminus of ETA/ETB receptors regulate endothelin-1 signal transmission.

Achani Yatawara1, Jamie L Wilson, Linda Taylor, Peter Polgar, Dale F Mierke.   

Abstract

The dimerization of the G protein-coupled receptors for endothelin-1 (ET-1), endothelin A receptor (ETA) and endolethin B receptor (ETB), is well established. However, the signaling consequences of the homodimerization and heterodimerization of ETA and ETB is not well understood. Here, we demonstrate that peptides derived from the C-termini of these receptors regulate the signaling capacity of ET-1. The C-termini of the ETA and ETB receptors are believed to consist of three α-helices, which may serve as points of interaction between the receptors. The third α-helix in the C-terminus is of particular interest because of its amphipathic nature. In a cell line expressing only the ETA receptor, expression of residues Y430-S442, representing the third helix of the ETB C-terminus, leads to a dramatic increase in the signaling induced by ET-1. In contrast, in a cell line containing only ETB , Y430-S442 has an antagonistic effect, slightly reducing the ET-1 induced signal. Computational docking results suggest that the α-helical ETB -derived peptide binds to the second and third intracellular loops of the ETA receptor consistent with the alteration of its signaling capacity. Our results described here provide important insight into ETA /ETB receptor interactions and possibly a new approach to regulate specific G protein-coupled receptor signal transmission.
Copyright © 2013 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23436727      PMCID: PMC3770155          DOI: 10.1002/psc.2499

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  31 in total

Review 1.  Endothelin(A)-endothelin(B) receptor cross-talk and endothelin receptor binding.

Authors:  Robert M Rapoport; Mario Zuccarello
Journal:  J Pharm Pharmacol       Date:  2011-07-19       Impact factor: 3.765

Review 2.  Current therapeutics and practical management strategies for pulmonary arterial hypertension.

Authors:  Richa Agarwal; Mardi Gomberg-Maitland
Journal:  Am Heart J       Date:  2011-07-13       Impact factor: 4.749

3.  Transgenic expression of an altered angiotensin type I AT1 receptor resulting in marked modulation of vascular type I collagen.

Authors:  Jun Yu; Linda Taylor; Celeste Rich; Paul Toselli; Philip Stone; Daniel Green; Rod Warburton; Nicholas Hill; Ronald Goldstein; Peter Polgar
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

4.  Activation of ERK, JNK, Akt, and G-protein coupled signaling by hybrid angiotensin II AT1/bradykinin B2 receptors expressed in HEK-293 cells.

Authors:  Jun Yu; David Lubinsky; Natia Tsomaia; Zhenhua Huang; Linda Taylor; Dale Mierke; Javier Navarro; Osman Miraz; Peter Polgar
Journal:  J Cell Biochem       Date:  2007-05-01       Impact factor: 4.429

5.  Role of hydroxyl containing residues in the intracellular region of rat bradykinin B(2) receptor in signal transduction, receptor internalization, and resensitization.

Authors:  G N Prado; D F Mierke; T LeBlanc; M Manseau; L Taylor; J Yu; R Zhang; R Pal-Ghosh; P Polgar
Journal:  J Cell Biochem       Date:  2001 Aug 21-Sep 5       Impact factor: 4.429

6.  Endothelin-1 activation of ETB receptors leads to a reduced cellular proliferative rate and an increased cellular footprint.

Authors:  Jamie L Wilson; Linda Taylor; Peter Polgar
Journal:  Exp Cell Res       Date:  2012-04-04       Impact factor: 3.905

7.  Enhancing and limiting endothelin-1 signaling with a cell-penetrating peptide mimicking the third intracellular loop of the ETB receptor.

Authors:  Christine O Sallum; Jamie L Wilson; Chamila Rupasinghe; Eric Berg; Jun Yu; Daniel S Green; Linda Taylor; Dale Mierke; Peter Polgar
Journal:  Chem Biol Drug Des       Date:  2012-06-27       Impact factor: 2.817

8.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

9.  PKC and MAPK signalling pathways regulate vascular endothelin receptor expression.

Authors:  David Nilsson; Angelica Wackenfors; Lotta Gustafsson; Martin Ugander; Richard Ingemansson; Lars Edvinsson; Malin Malmsjö
Journal:  Eur J Pharmacol       Date:  2007-11-01       Impact factor: 4.432

Review 10.  Mechanisms of disease: pulmonary arterial hypertension.

Authors:  Ralph T Schermuly; Hossein A Ghofrani; Martin R Wilkins; Friedrich Grimminger
Journal:  Nat Rev Cardiol       Date:  2011-06-21       Impact factor: 32.419

View more
  5 in total

1.  Validation of endothelin B receptor antibodies reveals two distinct receptor-related bands on Western blot.

Authors:  Travis P Barr; Daniel Kornberg; Jean-Pierre Montmayeur; Melinda Long; Stephen Reichheld; Gary R Strichartz
Journal:  Anal Biochem       Date:  2014-09-16       Impact factor: 3.365

2.  Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis.

Authors:  Tinazzi Elisa; Puccetti Antonio; Patuzzo Giuseppe; Barbieri Alessandro; Argentino Giuseppe; Confente Federico; Dolcino Marzia; Beri Ruggero; Marchi Giacomo; Ottria Andrea; Righetti Daniela; Rampudda Mariaelisa; Lunardi Claudio
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

3.  Endothelin inhibits renin release from juxtaglomerular cells via endothelin receptors A and B via a transient receptor potential canonical-mediated pathway.

Authors:  M Cecilia Ortiz-Capisano
Journal:  Physiol Rep       Date:  2014-12-18

Review 4.  Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting.

Authors:  David Speck; Gunnar Kleinau; Michal Szczepek; Dennis Kwiatkowski; Rusan Catar; Aurélie Philippe; Patrick Scheerer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-19       Impact factor: 6.055

5.  Fasudil inhibits hepatic artery spasm by repressing the YAP/ERK/ ETA/ETB signaling pathway via inhibiting ROCK activation.

Authors:  Xiaoguang Hao; Bo Shi; Weijing Li; Yongchao Wu; Ning Ai; Lina Zhu; Zhonglin Wu; Zhigang Li
Journal:  Aging (Albany NY)       Date:  2022-09-19       Impact factor: 5.955

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.